Shopping Cart
- Remove All
- Your shopping cart is currently empty
EZ-482 is a novel ligand of apolipoprotein (apoE). EZ-482 binds to apoE4 by a unique N-terminal allosteric effect and it also binds to sites on apoE in the C-terminal domain (Kds: 5-10 μM for apoE3 and apoE4).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $116 | 5 days | |
50 mg | $789 | 6-8 weeks | |
100 mg | $1,320 | 6-8 weeks |
Description | EZ-482 is a novel ligand of apolipoprotein (apoE). EZ-482 binds to apoE4 by a unique N-terminal allosteric effect and it also binds to sites on apoE in the C-terminal domain (Kds: 5-10 μM for apoE3 and apoE4). |
Targets&IC50 | ApoE3/ApoE4:(kd)5-10 μM |
In vitro | EZ-482 (0.5, 1, 5, 10 μM; 1 hour) blocks heparin-binding in a concentration-dependent manner. EZ-482 binds to sites on apoE in the C-terminal domain encompassing residues 229-243 and 258-265. |
Molecular Weight | 498.94 |
Formula | C23H19ClN4O5S |
Cas No. | 1016456-76-0 |
Relative Density. | 1.49 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.